Evaluation of Controlled Release Simvastatin around Dental Implant in Controlled Type II Diabetic Patient | ||||
| Al-Azhar Journal of Dentistry | ||||
| Volume 2023, Issue 2, April 2023 | ||||
| DOI: 10.58675/2974-4164.1541 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Salma Baheir1; Mai Attia2; Aya Dawaba3 | ||||
| 1Dentist at Medical Administration Center, Al-Azhar University, Cairo, Egypt | ||||
| 2Professor of Oral Medicine, Periodontology, Oral Diagnosis and Radiology, Faculty of Dental Medicine for Girls Al-Azhar University & Faculty of Oral and Dental Medicine, Misr International University, Cairo, Egypt | ||||
| 3Associate Professor of Pharmaceutics, Faculty of Pharmacy Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Purpose: The goal of this study was to evaluate the clinical effect of topically controlled release simvastatin with dental implant in type II diabetic patients. Materials and Methods: Sixteen diabetic type II patients with missing teeth were selected according to inclusion and exclusion criteria. Patients were divided randomly into two groups using flip coin method. Group I (test group): 8 patients underwent implant placement for missed tooth with controlled released simvastatin around the implant. Group II (control Group): 8 patients underwent implant placement for missed tooth without controlled released simvastatin around the implant. All patients were followed up clinically and radio-graphically for 6 months postoperatively after implant placement. Results: The use of Simvastatin controlled release gel with delayed dental implants decrease postoperative pain and swelling Conclusion: This research showed that the drug delivery system of controlled release simvastatin improve the repair and healing of bone and soft tissue around dental implant in diabetic type II patients | ||||
| Keywords | ||||
| dental implant; Diabetes type II; Simvastatin | ||||
|
Statistics Article View: 18 |
||||
